Panbela Therapeutics Valuation
| PBLADelisted Stock | USD 2.06 0.11 5.07% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Panbela Therapeutics holds a recent Real Value of $1.96 per share. The prevailing price of the company is $2.06. Our model determines the value of Panbela Therapeutics from analyzing the company fundamentals such as Number Of Shares Shorted of 106.97 K, return on equity of -7.98, and Shares Outstanding of 3.48 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Panbela Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Panbela Therapeutics is based on 3 months time horizon. Increasing Panbela Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Panbela Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Panbela Stock. However, Panbela Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.06 | Real 1.96 | Hype 2.06 |
The real value of Panbela Stock, also known as its intrinsic value, is the underlying worth of Panbela Therapeutics Company, which is reflected in its stock price. It is based on Panbela Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Panbela Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Panbela Therapeutics helps investors to forecast how Panbela stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Panbela Therapeutics more accurately as focusing exclusively on Panbela Therapeutics' fundamentals will not take into account other important factors: Panbela Therapeutics Total Value Analysis
Panbela Therapeutics is at this time expected to have valuation of 8.64 M with market capitalization of 3.93 M, debt of 6.84 M, and cash on hands of 2.53 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Panbela Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.64 M | 3.93 M | 6.84 M | 2.53 M |
Panbela Therapeutics Asset Utilization
One of the ways to look at asset utilization of Panbela is to check how much profit was generated for every dollar of assets it reports. Panbela Therapeutics holds a negative application of assets of -1.92 pct., losing $0.0192 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Panbela Therapeutics shows how discouraging it operates for each dollar spent on its assets.Panbela Therapeutics Ownership Allocation
Roughly 99.41 pct. of Panbela Therapeutics outstanding shares are held by general public with 0.59 (%) by third-party entities.Panbela Therapeutics Profitability Analysis
Net Loss for the year was (34.93 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Panbela Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Panbela Therapeutics and how it compares across the competition.
About Panbela Therapeutics Valuation
The delisted stock valuation mechanism determines Panbela Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Panbela Therapeutics. We calculate exposure to Panbela Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Panbela Therapeutics's related companies.Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota. Panbela Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
Panbela Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 27.8 K |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Panbela Stock
If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |